Condition
Acute COVID-19
Total Trials
4
Recruiting
1
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
P 4 (1)
Trial Status
Completed1
Not Yet Recruiting1
Recruiting1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07240649Phase 4Not Yet Recruiting
Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications
NCT07005947Active Not Recruiting
Long COVID-19 Cutaneous Signatures: An ARPA Funded Research Project
NCT05652634Completed
Chronic Stress as a Risk Factor for Long COVID
NCT05745805Recruiting
Cohort Follow-up of Epidemic and Neuroimaging for Patients During the 1st Wave of the COVID-19 in China
Showing all 4 trials